131 related articles for article (PubMed ID: 22284335)
1. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus.
von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335
[TBL] [Abstract][Full Text] [Related]
2. Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX.
von Suesskind-Schwendi M; Valenti V; Haneya A; Pühler T; Bewig B; Schmid C; Hirt SW; Lehle K
Histol Histopathol; 2013 Oct; 28(10):1273-84. PubMed ID: 23471704
[TBL] [Abstract][Full Text] [Related]
3. Lung transplantation in the fischer 344-wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the rat.
von Süßkind-Schwendi M; Ruemmele P; Schmid C; Hirt SW; Lehle K
Exp Lung Res; 2012 Apr; 38(3):111-23. PubMed ID: 22394285
[TBL] [Abstract][Full Text] [Related]
4. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
[TBL] [Abstract][Full Text] [Related]
5. Early administration of FTY720 prevents chronic airway as well as vascular destruction in experimental rat lung transplantation.
Hirt SW; von Suesskind-Schwendi M; Puehler T; Schmid C; Lehle K
Transplant Proc; 2013 Mar; 45(2):783-6. PubMed ID: 23498820
[TBL] [Abstract][Full Text] [Related]
6. Protective function of pirfenidone and everolimus on the development of chronic allograft rejection after experimental lung transplantation.
von Suesskind-Schwendi M; Heigel E; Pfaehler S; Haneya A; Schmid C; Hirt SW; Lehle K
Histol Histopathol; 2016 Jul; 31(7):793-805. PubMed ID: 26707547
[TBL] [Abstract][Full Text] [Related]
7. Everolimus's influence on persistent acute rejection after experimental lung transplantation.
Brunner E; Lehle K; Hirt SW; Schmid C; von Suesskind-Schwendi M
Adv Clin Exp Med; 2013; 22(3):355-9. PubMed ID: 23828676
[TBL] [Abstract][Full Text] [Related]
8. Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment.
Hirt SW; You XM; Möller F; Boeke K; Starke M; Spranger U; Wottge HU
J Heart Lung Transplant; 1999 Jun; 18(6):542-8. PubMed ID: 10395352
[TBL] [Abstract][Full Text] [Related]
9. Synergism of imatinib, vatalanib and everolimus in the prevention of chronic lung allograft rejection after lung transplantation (LTx) in rats.
Keil L; Schaub AL; Hirt SW; Schmid C; Lehle K; von Suesskind-Schwendi M
Histol Histopathol; 2019 Jul; 34(7):821-834. PubMed ID: 30706940
[TBL] [Abstract][Full Text] [Related]
10. The activity of nintedanib in an animal model of allogenic left lung transplantation resembling aspects of allograft rejection.
von Suesskind-Schwendi M; Boxhammer E; Hirt SW; Schreml S; Schmid C; Wollin L; Lehle K
Exp Lung Res; 2017; 43(6-7):259-270. PubMed ID: 29035589
[TBL] [Abstract][Full Text] [Related]
11. Assessment of pathological changes associated with chronic allograft rejection and tolerance in two experimental models of rat lung transplantation.
Matsumura Y; Marchevsky A; Zuo XJ; Kass RM; Matloff JM; Jordan SC
Transplantation; 1995 Jun; 59(11):1509-17. PubMed ID: 7778165
[TBL] [Abstract][Full Text] [Related]
12. Relevance of maintenance triple-drug immunosuppression to bridle the amplification of rat cytomegalovirus infection after experimental lung transplantation.
Lehle K; von Suesskind-Schwendi M; Diez C; Michl M; Geissler EK; Wottge HU; Schmid C; Hirt SW
Transpl Infect Dis; 2012 Dec; 14(6):649-56. PubMed ID: 22676701
[TBL] [Abstract][Full Text] [Related]
13. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-17 and airway inflammation: a longitudinal airway biopsy study after lung transplantation.
Snell GI; Levvey BJ; Zheng L; Bailey M; Orsida B; Williams TJ; Kotsimbos TC
J Heart Lung Transplant; 2007 Jul; 26(7):669-74. PubMed ID: 17613395
[TBL] [Abstract][Full Text] [Related]
15. Everolimus in lung transplantation in Chile.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):328-30. PubMed ID: 20172343
[TBL] [Abstract][Full Text] [Related]
16. Rat cytomegalovirus and Listeria monocytogenes infection enhance chronic rejection after allogenic rat lung transplantation.
Wiebe K; Fraund S; Steinmüller C; Steinhoff G
Transpl Int; 2005 Oct; 18(10):1166-74. PubMed ID: 16162104
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
18. A model of chronic lung allograft rejection in the rat.
Jungraithmayr W; Vogt P; Inci I; Hillinger S; Arni S; Korom S; Weder W
Eur Respir J; 2010 Jun; 35(6):1354-63. PubMed ID: 19840961
[TBL] [Abstract][Full Text] [Related]
19. A relevant experimental model for human bronchiolitis obliterans syndrome.
Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and treatment of chronic allograft nephropathy with everolimus.
Lutz J; Zou H; Liu S; Antus B; Heemann U
Transplantation; 2003 Aug; 76(3):508-15. PubMed ID: 12923436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
